Dr Reddy's Laboratories (RDY)

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Osakkeen Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) after-hours hinta tänään on 14,25 $ eli muutosta on ollut −0,84 % after-hours siitä, kun markkina viimeksi sulkeutui. Yrityksen markkina-arvo on 11,86 mrd. $, ja päivittäisen kaupankäynnin määrä on 2,01 milj. $ osaketta. Hintatrendejä seuraaville sijoittajille: osakkeen Dr. Reddy's Laboratories Limited American Depositary Shares hinnan vaihteluväli on ollut tänään 14,00 $ – 14,32 $. Edellinen sulkemishinta oli 14,37 $.

Aloitetaanko? Seuraa alla olevia vaiheita tai lue oppaamme siitä, miten ostaa Dr Reddy's Laboratories osakkeita Krakenista alkaen 10 dollarista.